Carrier Test Page
Save your life & Next Generation.
What is Aspartylglucosaminuria?
Aspartylglucosaminuria (AGU) is an inherited lysosomal storage disorder that affects the brain, bones, and connective tissue. This is due to a deficiency of the enzyme aspartylglucosaminidase. Children with AGU are normal for the first few years of life. They develop progressive intellectual disability that greatly affects speech. Other symptoms include weak bones that break easily, loose joints and skin, and frequent infections. Adults with AGU may have seizures and movement problems. Individuals with AGU usually survive into mid-adulthood. There is no cure for AGU; however medical surveillance and care may help to improve some symptoms and overall condition of life. AGU is caused by pathogenic variants in the AGA gene.
How is Aspartylglucosaminuria inherited?
AGU is inherited in an autosomal recessive manner. This type of inheritance requires the presence of two copies of a pathogenic variant in the gene for a person to have the genetic disease. Both parents must be carriers of a pathogenic variant in the gene in order to be at risk to have an affected child. The child must inherit a pathogenic variant from each carrier parent in order to be affected. There is a 1 in 4 chance that a baby will inherit two mutated copies of the gene and be affected when both parents are carriers.
What does it mean to be a carrier?
There are generally no signs or symptoms associated with being a carrier for AGU. However, the risk to have a child affected with AGU is increased. Testing of reproductive partners is recommended for carriers of AGU.
How common is Aspartylglucosaminuria?
What is analysed?
|Ethnicity||Detection Rate||Carrier Frequency|
|General Population||> 83%||1 in 500|